Table of Contents
From the Editor
- Outcome measures need context
The patient in front of me may differ from those seen in a clinical trial and may care about other outcome measures.
1-Minute Consult
- Should we be concerned about thyroid cancer in patients taking glucagon-like peptide 1 receptor agonists?
The risk in humans is difficult to quantify, but low.
The Clinical Picture
- Pneumatosis cystoides intestinalis: Is surgery always indicated?
This disease is usually benign, but evidence of necrosis or pneumoperitoneum warrants immediate surgery.
Smart Testing
- Does this patient need ultrasonography of the leg to evaluate for deep vein thrombosis?
If the pretest probability of deep vein thrombosis is low, a normal D-dimer level is enough to rule it out.
Im Board Review
- When the dissociation curve shifts to the left
The patient’s clinical signs and oxygen saturation monitor indicated hypoxemia, but her blood gases were normal.
Review
- Is triglyceride therapy worth the effort?
Levels do matter, but no trials of triglyceride-lowering have been done. Weight loss and exercise are encouraged.
Left atrial appendage closure: An emerging option in atrial fibrillation when oral anticoagulants are not toleratedCan patients undergo a percutaneous procedure to reduce their risk of stroke and avoid lifelong anticoagulation treatment?
- Managing aneurysmal subarachnoid hemorrhage: It takes a team
There is no silver bullet, but systematic application of small advances maximizes the patient’s chance of recovery.
Departments
- Diabetes therapy and cardiac risk (November 2014)
A reader comments on diabetes therapy and cardiac risk (November 2013).
- In Reply: Diabetes therapy and cardiac risk (November 2014)
A reader comments on diabetes therapy and cardiac risk (November 2013).
Commentary
Before dispensing advice, we should know the effect of what we recommend on all meaningful outcomes.